샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514028

세계의 바이오 이미징 기술 시장

BioImaging Technologies
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 174 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 바이오 이미징 기술 시장은 2030년까지 316억 달러에 달할 전망

2023년에 119억 달러로 평가된 세계의, 바이오 이미징 기술 시장은 분석기간 2023년부터 2030년까지 CAGR 15.0%로 성장할 전망이며, 2030년에는 316억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 의료기술은 CAGR 14.7%로 성장을 지속하고, 분석 기간 종료 시에는 195억 달러에 달할 것으로 예측됩니다. 분자 기술 분야의 성장률은 분석 기간 동안 CAGR 15.5%로 추정됩니다.

미국 시장은 33억 달러로 추정, 중국은 CAGR 14.2%로 성장 예측

미국의 바이오 이미징 기술 시장은 2023년 33억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 48억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 14.2%로 전망됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 13.0%와 12.6%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 10.7%로 성장할 것으로 예측됩니다.

세계의 바이오 이미징 기술 시장-주요 동향 및 촉진요인 요약

바이오 이미징 기술은 생물학적 과정을 실시간으로 시각화함으로써 의학에 혁명을 가져왔습니다. 해부학적 구조 정보와 전기장, 자기장, 기계적 운동, 대사 과정 등의 기능적 데이터를 결합함으로써 생체이미징은 인체 내부의 구조를 종합적으로 볼 수 있습니다. X선, 초음파, MRI, 고급 CT 스캔 등의 기술은 해부학 및 세포 구조의 상세한 이미지를 공개하고 질병 진단 및 관리에 매우 중요합니다. 이러한 비침습적 방법은 물리적 침입 없이 상세한 검사를 가능하게 하고, 임상 현장에서 매우 귀중한 것이 되고 있습니다. 바이오 이미징은 복잡한 생물학적 문제를 해결하기 위해 전기공학, 기계공학, 생물의학공학을 통합한 학제간 분야이며, 암 등의 질병의 이해와 치료에 큰 진보를 가져왔습니다.

바이오 이미징의 진보는 컴퓨팅 생물학과 바이오인포매틱스에 깊이 뿌리를 두고 있으며 세포와 분자 이미지의 높은 처리량 분석에 초점을 맞추었습니다. 최신 자동 현미경과 첨단 계산 기법은 인간의 개입을 최소화하면서 데이터 분석의 정확성과 효율성을 향상시킵니다. 다광자 이미징, 이미지 유도 인터벤션, 다양한 현미경 기술 등의 혁신은 의료 진단 및 치료 계획의 능력을 확대해 왔습니다. 바이오 이미징에서 중요한 과제 중 하나는 이미지 처리 기법 계산의 복잡성과 함께 이미지 재구성과 관련된 수치적 불안정성입니다. 최근의 동향은 인공지능(AI)과 머신러닝을 통합하여 이미지 분석을 강화하고 원시 데이터를 실용적인 의료 통찰력으로 변환하는 것을 포함합니다.

바이오 이미징 기술의 성장에는 몇 가지 중요한 요소가 있습니다. AI와 머신러닝의 발전으로 보다 정교한 분석이 가능하며 진단 정확도와 효율성이 향상됩니다. 향상된 컴퓨팅 능력과 우수한 알고리즘을 통해 보다 빠르고 안정적인 이미지 처리가 가능합니다. 맞춤형 의료에 대한 요구가 증가함에 따라, 개인의 생리학적 및 분자학적 프로파일에 기초한 치료법을 조정하기 위한 고급 이미징 기술이 필요합니다. 생물 의학 연구를 확대하려면 세포 수준과 분자 수준에서 생물학적 과정을 관찰하고 분석해야 하며 고급 이미징 도구의 필요성을 뒷받침합니다. 특히 신흥국에서의 헬스케어 지출 증가가 바이오이미징의 채용을 뒷받침하고 있습니다. 조기 및 정확한 진단에 대한 환자 의식 증가와 기대는 규제 당국의 지원 정책 및 이미징 기술의 비용 절감과 함께 건강 관리에서 바이오 이미징 시스템의 보급을 더욱 촉진하고 있습니다. 이러한 요인들이 종합적으로 현대의 의료·과학 영역에서의 바이오 이미징의 중요한 역할을 뒷받침하고 있습니다.

조사 대상 기업 예(주목 14사)

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

AJY 24.07.24

Global BioImaging Technologies Market to Reach US$31.6 Billion by 2030

The global market for BioImaging Technologies estimated at US$11.9 Billion in the year 2023, is expected to reach US$31.6 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Medical Technology, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$19.5 Billion by the end of the analysis period. Growth in the Molecular Technology segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 14.2% CAGR

The BioImaging Technologies market in the U.S. is estimated at US$3.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global BioImaging Technologies Market - Key Trends and Drivers Summarized

Bioimaging technologies have revolutionized medical sciences by providing real-time visualization of biological processes. Combining anatomical structure information with functional data such as electrical and magnetic fields, mechanical motion, and metabolic processes, bioimaging offers a comprehensive view of the human body's internal workings. Techniques like X-rays, ultrasound, MRI, and advanced CT scans reveal detailed images of anatomical and cellular structures, crucial for diagnosing and managing diseases. These non-invasive methods allow for detailed examination without physical intrusion, making them invaluable in clinical settings. Bioimaging is an interdisciplinary field integrating electrical, mechanical, and biomedical engineering to address complex biological questions, leading to significant advancements in understanding and treating diseases like cancer.

The advancement of bioimaging is deeply rooted in computational biology and bioinformatics, focusing on high-throughput analysis of cellular and molecular images. Modern automated microscopes and sophisticated computational methods enhance the accuracy and efficiency of data analysis with minimal human intervention. Innovations such as multi-photon imaging, image-guided interventions, and various microscopy techniques have expanded the capabilities of medical diagnostics and therapeutic planning. One critical challenge in bioimaging is the numerical instability associated with image reconstruction, alongside the computational complexity of image processing methods. Recent developments include integrating Artificial Intelligence (AI) and machine learning to enhance image analysis, transforming raw data into actionable medical insights.

Several key factors drive the growth of bioimaging technologies. Advancements in AI and machine learning enable more sophisticated analysis, improving diagnostic accuracy and efficiency. Enhanced computational power and better algorithms allow for faster and more reliable image processing. The increasing demand for personalized medicine necessitates advanced imaging technologies to tailor therapies based on individual physiological and molecular profiles. Expanding biomedical research requires observing and analyzing biological processes at cellular and molecular levels, driving the need for advanced imaging tools. Rising healthcare expenditure, particularly in emerging economies, supports the adoption of bioimaging. Higher patient awareness and expectations for early and accurate diagnoses, along with supportive regulatory policies and cost reductions in imaging technology, further promote the widespread use of bioimaging systems in healthcare. These factors collectively underscore the significant role of bioimaging in modern medical and scientific domains.

Select Competitors (Total 14 Featured) -

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • BioImaging Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Advanced Diagnostic Imaging Techniques
    • Growth of Chronic Diseases and Aging Population
    • Advancements in Imaging Modalities and Technologies
    • Rising Adoption of Molecular Imaging and PET Scans
    • Impact of COVID-19 Pandemic on BioImaging Market
    • Government Regulations and Standards for Medical Imaging Devices
    • Expansion of BioImaging Applications in Drug Discovery and Development
    • Development of AI and Machine Learning in BioImaging Analysis
    • Consumer Preferences for Non-Invasive Diagnostic Procedures
    • Role of BioImaging in Personalized Medicine and Targeted Therapies
    • Market Penetration of BioImaging in Oncology and Neurology
    • Influence of Technological Innovations on BioImaging Accuracy and Speed
    • Growth of BioImaging in Academic and Research Institutions
    • Challenges Related to Data Management and Storage in BioImaging
    • Emerging Markets and Growth Opportunities in Developing Regions
    • Future Trends and Innovations in BioImaging Technologies and Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World BioImaging Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CHINA
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제